Search Results 61-70 of 16806 for Flutamide
... flutamide) or 6 weeks (for bicalutamide or nilutamide) prior to randomization; If demonstrates an anti-androgen withdrawal response, defined as a ≥ 25 ...
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Prior systemic treatment with androgen deprivation therapy and/or first-generation anti-androgen (e.g., bicalutamide, nilutamide, flutamide) for biochemically ...
Diroximel fumarate is used to treat the relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and ...
Patients who received a first generation anti-androgen (for example, bicalutamide, flutamide, nilutamide) must have at least a 4-week washout prior to ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
Tolnaftate belongs to the group of medicines called antifungals. It is used to treat some types of fungus infections. It may also be used together with ...
Aclidinium and formoterol combination is used as maintenance treatment in patients with chronic obstructive pulmonary disease (COPD). It will not relieve a COPD ...
Safinamide is used in combination with levodopa and carbidopa to treat adults with Parkinson's disease who are having "off" episodes. This medicine is a MAO-B ...
Prohibited 3 months before participant registration and during administration of study treatment: non-steroidal anti-androgens (e.g., bicalutamide, flutamide ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.